​

Jade Biosciences (JBIO) Stock Forecast, Price Target & Predictions

OverviewOwnershipChart

JBIO Stock Forecast

Jade Biosciences (JBIO) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $32.50, with a high of $40.00 and a low of $25.00. This represents a 48.54% increase from the last price of $21.88.

JBIO Stock Rating

Jade Biosciences stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 4 Strong Sell Sell Hold Buy Strong Buy

JBIO Price Target Upside V Benchmarks

TypeNameUpside
StockJade Biosciences48.54%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-15
Avg Price Target-$40.00$25.20
Last Closing Price$21.88$21.88$21.88
Upside/Downside-82.82%15.17%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 26-9---9
Mar, 26-7---7
Feb, 26-7---7
Jan, 26-6---6
Dec, 25-6---6
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 06, 2026Alex ThompsonStifel Nicolaus$40.00$14.07184.29%82.82%
Jan 07, 2026H.C. Wainwright$25.00$13.1789.83%14.26%
Oct 09, 2025BTIG$28.00$9.08208.37%27.97%
Jun 16, 2025Vamil DivanGuggenheim$14.00$6.76107.10%-36.01%
May 05, 2025Alex ThompsonStifel Nicolaus$19.00$11.5065.22%-13.16%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 25, 2026H.C. WainwrightBuyBuyhold
Jan 07, 2026H.C. WainwrightBuyinitialise
Oct 09, 2025BTIGBuyinitialise
Jun 16, 2025GuggenheimBuyupgrade
May 07, 2025WedbushOutperforminitialise

Financial Forecast

EPS Forecast

$-20 $-16 $-12 $-8 $-4 $0 Dec 24 Dec 25 Dec 26 Dec 27
Dec 24Dec 25Dec 26Dec 27
Reported$-18.79---
Avg Forecast$-18.79$-2.43$-1.96$-2.36
High Forecast$-18.79$-1.16$-1.67$-2.27
Low Forecast$-18.79$-3.09$-2.15$-2.45
Surprise %----

Revenue Forecast

Dec 24 Dec 25 Dec 26 Dec 27
Dec 24Dec 25Dec 26Dec 27
Reported----
Avg Forecast----
High Forecast----
Low Forecast----
Surprise %----

Net Income Forecast

$-95K $-77K $-59K $-41K $-23K $-5K Dec 24 Dec 25 Dec 26 Dec 27
Dec 24Dec 25Dec 26Dec 27
Reported$-93.96K---
Avg Forecast$-93.98K$-10.63K$-9.55K$-11.80K
High Forecast$-93.98K$-5.80K$-8.35K$-11.35K
Low Forecast$-93.98K$-15.45K$-10.75K$-12.25K
Surprise %-0.02%---

JBIO Forecast FAQ

Is Jade Biosciences stock a buy?

Jade Biosciences stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Jade Biosciences is a favorable investment for most analysts.

What is Jade Biosciences's price target?

Jade Biosciences's price target, set by 4 Wall Street analysts, averages $32.5 over the next 12 months. The price target range spans from $25 at the low end to $40 at the high end, suggesting a potential 48.54% change from the previous closing price of $21.88.

How does Jade Biosciences stock forecast compare to its benchmarks?

Jade Biosciences's stock forecast shows a 48.54% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Jade Biosciences over the past three months?

  • April 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Jade Biosciences’s EPS forecast?

Jade Biosciences's average annual EPS forecast for its fiscal year ending in December 2025 is $-2.43, marking a -87.07% decrease from the reported $-18.79 in 2024. Estimates for the following years are $-1.96 in 2026, and $-2.36 in 2027.

What is Jade Biosciences’s revenue forecast?

Jade Biosciences's average annual revenue forecast for its fiscal year ending in December 2025 is $0, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $0, and $0 for 2027.

What is Jade Biosciences’s net income forecast?

Jade Biosciences's net income forecast for the fiscal year ending in December 2025 stands at $-10.627K, representing a -88.69% decrease from the reported $-93.958K in 2024. Projections indicate $-9.552K in 2026, and $-11.802K in 2027.